PISANO CARLO MARIA

Ruolo: 
Docente a contratto

Pubblicazioni

  • Lorusso, D., Hilpert, F., Gonzalez Martin, A., Rau, J., Ottevanger, P., Greimel, E., et al. (2019). Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 29(7), 1141-1147. Dettaglio